NICE wishes you a cost effective Christmas
November 30, 2011Sales and Marketing NICE
NICE has disclosed information about its use of corporate credit cards following a request made under the Freedom of Information …
Eli Lilly appoints Richard Ascroft as senior director for the ACE region
November 30, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly
Lilly has appointed Richard Ascroft as senior director, corporate affairs, for the Australia, Canada and Europe (ACE) region. His tasks …
Roche inks $490 million deal with PTC Therapeutics
November 30, 2011Research and Development, Sales and Marketing PTC Therapeutics, Roche
Roche has signed a $490 million deal with specialist biotech firm PTC Therapeutics. Roche is paying PTC $30 million upfront …
NICE rejects Lucentis in diabetic macular oedema
November 29, 2011Sales and Marketing Lucentis, NICE
NICE has rejected Novartis’ Lucentis for diabetic macular oedema. NICE has not recommended Lucentis (ranibizumab) for the treatment of diabetic …
Merck and Merck look to settle Facebook naming dispute
November 29, 2011Medical Communications Facebook, Merck, Merck KGaA
Merck & Co and Merck KGaA looked to have made inroads into their Facebook naming quarrel. Earlier this month Merck …
Cerenis appoints John Paolini as chief medical officer
November 29, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cerenis
The HDL drug specialist Cerenis Therapeutics has appointed Dr John Paolini as its new chief medical officer. Dr Paolini will …
Pharma manufacturing news in brief
November 29, 2011Manufacturing and Production NIB, manufacturing and production
Fujifilm inks another biosimilars deal, an explosion rocks an Aurobindo plant, plus manufacturing updates from Teva, Bellwyck Packaging and Indian …
FDA gives green light to BioMarin facility expansion
November 29, 2011Manufacturing and Production
The US FDA has granted approval to BioMarin Pharmaceutical for a $60 million expansion of its manufacturing facility in Novato, …
Abbott expands diagnostic pact with GlaxoSmithKline
November 29, 2011Research and Development, Sales and Marketing Abbott, Cancer, GSK, non-small cell lung cancer
Abbott will develop a diagnostic kit for GlaxoSmithKline’s new lung cancer drug candidate. This is an expansion of a …
Roche opens $271m formulations centre
November 29, 2011Manufacturing and Production Roche, manufacturing
Roche has officially opened a 250 million Swiss franc ($271m) R&D centre in Switzerland that will be used to develop …
Onglyza cleared for use with insulin
November 29, 2011Sales and Marketing AstraZeneca, Merck, Onglyza, diabetes, insulin
European regulators have approved a licence extension for Bristol-Myers Squibb and AstraZeneca’s type II diabetes treatment Onglyza. The oral DPP-4 …
Catalent Pharma Solutions Appoints New Vice President and General Manager – Sterile Technologies
November 28, 2011Manufacturing and Production
Catalent Pharma Solutions, Inc. announced the appointment of Jonathan Arnold as Vice President and General Manager – Sterile Technologies effective …
Munro & Forster win PRCA Health and Wellbeing Award
November 28, 2011Medical Communications COPD, ERS, Munro & Forster, PRCA
Healthcare comms agency Munro & Forster has won an industry award for its innovative World Spirometry Day Campaign for the …
Janssen sets up new mental health social networking site
November 28, 2011Medical Communications J&J, JJ, Janssen, NHS
Janssen and the NHS Confederation have established a new mental health social networking site. The service, which will be free …
UK government drops Cervarix for Gardasil
November 28, 2011Sales and Marketing Cervarix, GSK, Gardasil, MSD, Sanofi
The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …
UCB appoints Peter Theil as head of non-clinical development
November 28, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB
Peter Theil has joined UCB as its new vice president and head of non-clinical development for the firm’s new medicines …
Pfizer to acquire skin specialist firm Excaliard
November 28, 2011Sales and Marketing EXC 001, Excaliard, Pfizer
Pfizer will acquire skin specialist Excaliard Pharmaceuticals as the firm looks to further diversify its pipeline. Financial terms of the …
Shire facility could answer rare disease drug shortage
November 27, 2011Manufacturing and Production Fabry disease, Gaucher, Shire, Vpriv
Shire has filed applications with the European and US regulators to produce its Gaucher disease drug Vpriv (velaglucerase alfa) at …
Pfizer’s Loughbeg first pharma facility to meet green standard
November 27, 2011Manufacturing and Production ISO 50001, Loughbeg, Pfizer, environmental
A Pfizer facility in Ireland has become the first pharmaceutical plant in the world to meet a tough new standard …
The changing of the guard – Q3 round up
November 25, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lipitor, Q3, Ranbaxy
PfizerOf all the patent cliffs in pharma, Lipitor’s expiry represents the biggest. Pfizer is now staring over the precipice, with …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
